Jones Hill Capital as of March 31, 2026
Portfolio Holdings for Jones Hill Capital
Jones Hill Capital holds 26 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical (BMRN) | 15.4 | $72M | 1.3M | 56.49 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 10.4 | $49M | 109k | 446.54 | |
| Vaxcyte (PCVX) | 8.0 | $38M | 645k | 58.11 | |
| Nuvalent Inc-a (NUVL) | 6.6 | $31M | 301k | 102.45 | |
| Capricor Therapeutics Com New (CAPR) | 5.9 | $28M | 909k | 30.40 | |
| Terns Pharmaceuticals (TERN) | 5.9 | $28M | 521k | 52.72 | |
| Bicara Therapeutics (BCAX) | 5.4 | $25M | 1.3M | 19.89 | |
| Biosante Pharmaceuticals (ANIP) | 5.3 | $25M | 319k | 76.90 | |
| Ultragenyx Pharmaceutical (RARE) | 5.2 | $24M | 1.2M | 20.95 | |
| Enliven Therapeutics (ELVN) | 5.0 | $23M | 593k | 39.20 | |
| Amylyx Pharmaceuticals (AMLX) | 4.8 | $22M | 1.6M | 13.90 | |
| Argenx Se Sponsored Adr (ARGX) | 4.1 | $19M | 26k | 730.25 | |
| Fulcrum Therapeutics (FULC) | 2.9 | $14M | 1.8M | 7.67 | |
| Vir Biotechnology (VIR) | 2.3 | $11M | 1.2M | 8.96 | |
| Nuvation Bio Com Cl A (NUVB) | 2.2 | $10M | 2.4M | 4.29 | |
| Oruka Therapeutics (ORKA) | 1.5 | $6.9M | 141k | 49.05 | |
| Contineum Therapeutics Cl A (CTNM) | 1.4 | $6.7M | 513k | 13.06 | |
| Veradermics Common Stock | 1.4 | $6.4M | 101k | 63.15 | |
| Tonix Pharmaceuticals Hldg C Com New (TNXP) | 1.3 | $6.2M | 452k | 13.75 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.0 | $4.8M | 101k | 48.20 | |
| Entrada Therapeutics (TRDA) | 1.0 | $4.7M | 374k | 12.62 | |
| Pharvaris N V (PHVS) | 1.0 | $4.7M | 167k | 28.25 | |
| Trevi Therapeutics (TRVI) | 0.9 | $4.4M | 370k | 11.93 | |
| Relmada Therapeutics (RLMD) | 0.5 | $2.4M | 343k | 6.96 | |
| Silence Therapeutics Ads (SLN) | 0.3 | $1.6M | 302k | 5.27 | |
| Arrivent Biopharma (AVBP) | 0.2 | $1.1M | 46k | 23.07 |
